Ginascol John F has filed 4 insider transactions across 1 company since February 2023.
Most recent transaction: a tax payment of 6859 shares of ABBOTT LABORATORIES ($ABT) on February 28, 2023.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 28, 2023 | ABBOTT LABORATORIES | $ABT | Ginascol John F | EXECUTIVE VICE PRESIDENT | F | Common shares without par value | 6859 | $99.77 | 119,323.0000 | 1,986,519,278 | 5.44% | 0.00% |
| March 1, 2023 | ABBOTT LABORATORIES | $ABT | Ginascol John F | EXECUTIVE VICE PRESIDENT | S | Common shares without par value | 943 | $100.70 | 118,380.0000 | 1,986,519,278 | 0.79% | 0.00% |
| Feb. 17, 2023 | ABBOTT LABORATORIES | $ABT | Ginascol John F | EXECUTIVE VICE PRESIDENT | A | Common shares without par value | 14270 | $0.00 | 126,182.0000 | 1,986,519,278 | 12.75% | 0.00% |
| Feb. 17, 2023 | ABBOTT LABORATORIES | $ABT | Ginascol John F | EXECUTIVE VICE PRESIDENT | A | Option (right to buy) | 56275 | $0.00 | 56,275.0000 | 1,986,519,278 | 9999.99% | 0.00% |